Yang Xiaofang, Deputy Secretary General of CAMDI
Jiang Deyuan, Senior Advisor of CAMDI, said in his address that health is an eternal theme in the development and progress of human society, while drugs and medical devices are an essential material base indispensable to people’s health. Medical device industry is highly valued by the Party and the government and receives extensive attention from the society for its significant public health, economic, scientific and technological attributes. Under the driving effect of a series of favorable policies, the medical device industry of China maintains a high growth rate, with main segments becoming the focus of innovation and development, including artificial intelligence and medical imaging. Significant progresses have been made in the combination of artificial intelligence and medicine, which has practically improved the efficiency of medical diagnosis and greatly relieved the burden of physicians; remarkable achievements have also been made in the research and application of cutting-edge medical imaging technologies. He also said that CAMDI, as a bridge between government, industry and sector, plays an important role that cannot be replaced; in the future, CAMDI will continue efforts to assist the government with policy implementation, promote industrial self-discipline, strengthen credit construction, improve professional quality, and drive industry innovation and high-quality development and so forth. Moreover, he expressed his wish that relevant governmental departments and all related parties of the industry continue to care about and support the work of CAMDI and jointly promote the high-quality development of medical device industry in China.
Jiang Deyuan, Senior Advisor of China Association for Medical Devices Industry
Zhou Shaohua, Professor at the University of Technology and Science of China and Founding Executive Dean of the School of Biomedical Engineering, shared the characteristics and technologies of the common basic AI model for medical imaging, and elaborated on current difficulties and challenges about the model and the development trends to cover more modalities, incorporate more data and undertake more tasks.
Zhou Shaohua, Professor at the University of Technology and Science of China and Founding Executive Dean of the School of Biomedical Engineering
Liu Xiaoyin from the Center for Medical Device Evaluation of National Medical Products Administration mainly introduced the operation conditions of the AI-based medical device innovation cooperation platform and the achievements made over five years since its establishment.
Liu Xiaoyin from the Center for Medical Device Evaluation of National Medical Products Administration
Lu Jie, Vice President of Xuanwu Hospital of Capital Medical University, comprehensively analyzed the current clinical application of artificial intelligence and imaging technology and carried out in-depth and detailed exploration on relevant application requirements.
Lu Jie, Vice President of Xuanwu Hospital of Capital Medical University
He Xujin, Group General Manager of Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Dr. Zhan Yiqiang from Shanghai United Imaging Intelligent Medical Technology Co., Ltd., Dr. Wan Yiting from Careverse, Dr. Huang Feng from GE Healthcare Hangwei Co., Ltd., Zhang Chen, Director of Olympus (Suzhou) Medical Device Co., Ltd., and Yan Ke, Director of Alibaba DAMO Academy for Discovery, Adventure, Momentum and Outlook, introduced the cutting-edge research results in AI-based medical devices and medical imaging, and the development situation of the industry.
He Xujin, Group General Manager of Shenzhen Mindray Biological Medical Electronics Co., Ltd.
Dr. Zhan Yiqiang from Shanghai United Imaging Intelligent Medical Technology Co., Ltd.
Dr. Wan Yiting from Careverse
Dr. Huang Feng from GE Healthcare Hangwei Co., Ltd.
Zhang Chen, Director of Olympus (Suzhou) Medical Device Co., Ltd.
Yan Ke, Director of Alibaba DAMO Academy for Discovery, Adventure, Momentum and Outlook
During this seminar, the guests shared their ideas on and interpreted the research and use of artificial intelligence and medical imaging technology in a meticulous and deep-going way, which provided inspiration for a series of constructive thoughts to cope with difficulties in industry innovation and development. We hope that all related parties will actively put the results of this seminar into practice, to drive the industry forward and make more contributions to the healthcare career.